gastroesophageal junction adenocarcinoma
Showing NaN - NaN of 15
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Bemarituzumab
- +3 more
-
Phoenix, Arizona
- +119 more
Feb 1, 2023
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),
Recruiting
- Gastric Cancer
- +2 more
- Evorpacept (ALX148)
- +3 more
-
Anaheim, California
- +54 more
Jan 23, 2023
Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily
Recruiting
- Solid Tumor
- +8 more
- TPST-1495 twice daily
- +2 more
-
Baltimore, Maryland
- +8 more
Jan 4, 2023
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- tucatinib
- +5 more
-
Birmingham, Alabama
- +47 more
Oct 27, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +27 more
- Carboplatin
- +4 more
-
Anchorage, Alaska
- +469 more
Aug 24, 2022
Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States
Terminated
- Pancreatic Adenocarcinoma
- +13 more
- GB1275
- +2 more
-
San Francisco, California
- +7 more
Aug 17, 2022
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +12 more
-
Nashville, Tennessee
- +4 more
Feb 3, 2022
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Fayetteville, Arkansas
- +134 more
Jul 29, 2021
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)
Completed
- Gastric Cancer
- +3 more
-
Santa Monica, California
- +27 more
Jan 18, 2021
Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville
Completed
- Advanced Cancer
- +5 more
-
Boston, Massachusetts
- +3 more
Nov 24, 2020
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019